Gynecologic cancer survivorship management

Over the past three decades, the number of gynecologic cancer survivors has grown substantially, most notably among women with early-stage disease. Cure of gynecologic cancers is possible with evidence-based and tailored combinations of surgery, chemotherapy, and radiation therapy. The ability to identify genetic predispositions to specific gynecologic malignancies has also positively affected gynecologic cancer survivors. Algorithms have been developed to provide appropriate survivorship care for patients with gynecologic malignancies. Each algorithm is geared toward care of survivors with a specific disease history. Surveillance tests and examinations, as well as risk reduction and early detection strategies, are recommended for survivors of each gynecologic malignancy. Monitoring schedules and testing methods for late effects and psychosocial functioning (including referrals, when appropriate) are also provided. As the field of cancer survivorship develops and the number of gynecologic cancer survivors grows, these algorithms will become increasingly important. Many survivors suffer from long-term cancer- and treatment-related morbidities. We must recognize that the care of survivors extends far past their 5-year survival period, and that some late effects of treatment continue to worsen over time. Additionally, caregiver responsibilities, with subsequent benefits and stressors, must also be further evaluated and supported. The quality of life of each survivor affects and is affected by every member of her team, including her family caregivers.